Browse studies

Find your next paid study

27,370 recruiting studies available now

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

This study is being done to establish "normal' values for a new blood test and urine test approach to cancer screening. Patients undergo blood and urine sample…

Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT06192875

Phase 1

A Phase 1b and 2 Study of Roginolisib (IOA-244) Combined With Obinutuzumab Followed by Venetoclax in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) After Progression on Prior Bruton Tyrosine Kinase (BTK) Inhibitors

This is a Phase 1b and 2, open-label, single-arm study evaluating the safety, tolerability, and efficacy of roginolisib (IOA-244) in combination with obinutuzu…

Chronic Lymphocytic Leukemia (CLL)Refractory Chronic Lymphocytic Leukemia

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT07847957

Phase 4

Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery

We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which in…

Laparoscopic Adnexal Surgery

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of TennesseeNCT06842771

Phase 3

A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre Trial Comparing Efficacy and Safety of Trilaciclib Versus Placebo in Participants With Limited-stage Small Cell Lung Cancer

The goal of this clinical trial is to compare the efficacy and safety of trilaciclib versus placebo in subjects with limited stage small cell lung cancer. The …

Limited Stage Small Cell Lung Cancer

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Pharmacosmos A/SNCT07473128

Observational

Randomized Controlled Trial of Electronic Clinical Decision Support Systems for Improving Care Management and Clinical Outcomes for Adults With Steatotic Liver Disease

The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decisio…

MASLD

Estimated

~$10 – $750

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT07382349

Phase 2

An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency

This is a multi-national trial. The trial aims to study the long-term safety of LUM-201 in subjects with Idiopathic Pediatric Growth Hormone Deficiency (iPGHD)…

Growth Hormone Deficiency

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Lumos PharmaNCT05796440

Phase 1

A Phase 1b/2 Study to Demonstrate the Safety and Efficacy of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an Ileal Pouch-Anal Anastomosis (PROF). The "PROF" Study.

The aim of this study is to assess the safety and preliminary efficacy of treatment with EXE-346, a live biotherapeutic, which may reduce bowel movement freque…

Ileal Pouch

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Exegi Pharma, LLCNCT05938465

Phase 3

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy: A Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Prostate CancerProstatic Neoplasms

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Clarity Pharmaceuticals LtdNCT06056830

OneRF® Ablation System Post-Market Real-World Evidence Registry

This is a multi-site registry study that aims to collect real-world clinical outcomes and device performance of the OneRF Ablation System. The study focuses on…

Drug Resistant EpilepsyRefractory Epilepsy

Estimated

~$10 – $1,050

Actual pay is set by the research site.

NeuroOne Medical Technologies CorporationNCT07546253

Observational

MEDBRIDGE: AI-Driven Risk Stratification and Care Transition Intervention to Improve Diabetes Medication Management

This study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medicati…

Type 2 DiabetesMedication AdherenceCare Transition+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Alabama at BirminghamNCT07599852

Phase 1

A Seamless Phase 1/2 Open-label Study to Evaluate the Safety, Determine the Maximum Tolerated Dose of Administered Activity, and Evaluate the Efficacy of the Therapeutic Radiopharmaceutical [Ac 225]-RTX-2358 in the Treatment of Relapsed or Refractory Sarcoma

The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio …

Advanced Soft Tissue Sarcoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ratio Therapeutics, Inc.NCT07156565

An Observational Long-term Follow-up Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)

This observational long-term follow-up study is designed to collect safety and efficacy data from ADA-SCID patients previously treated with autologous ex vivo …

Adenosine Deaminase DeficiencySevere Combined Immunodeficiency (SCID)

Estimated

Pay not disclosed — ask the coordinator

University of California, Los AngelesNCT04049084